Sympathetic blocks in the treatment of erythromelalgia: case series
Semih Gungor1,2, Burcu Candan1,3
1Division of Musculoskeletal and Interventional Pain Management, Department of Anesthesiology, Critical Care and Pain Management, Hospital for Special Surgery, New York, NY, USA.
Background:
Erythromelalgia (EM) is a rare, debilitating condition characterized by episodic burning pain, erythema, and increased skin temperature, typically affecting the distal extremities. EM significantly impairs quality of life (QoL) and may lead to functional disability. Although its pathophysiology is not fully understood, proposed mechanisms include small fiber nerve dysfunction and dysregulation of the sympathetic nervous system. Management remains challenging, with no universally effective treatment currently available.
Case Presentation:
We present three patients with refractory lower extremity erythromelalgia treated with lumbar sympathetic block (LSB). All patients had chronic treatment-refractory symptoms and had failed multiple prior treatments, including neuropathic medications and conservative measures. Bilateral L3 LSBs were performed using a standardized approach. Two patients experienced substantial symptom improvement, with reported reductions in pain intensity and a prolonged benefit lasting several months. One patient demonstrated partial, short-term improvement. Repeated LSB procedures were performed in cases of symptom recurrence.
Conclusion:
In this retrospective case series, LSB was associated with symptomatic improvement in selected erythromelalgia patients, potentially by modulating sympathetic activity and regional blood flow. However, given the small sample size and retrospective design, no conclusions regarding efficacy can be drawn. Further studies are needed to better define patient selection criteria and long-term outcomes.
Related Concept Videos
Antianginal Drugs: Nitrates and β-Blockers
Organic nitrates, such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow. Administered...
Antianginal Drugs: Calcium Channel Blockers and Ranolazine
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
Adrenergic Antagonists: Chemistry and Classification of ɑ-Receptor Blockers
Nonselective α-blockers: Nonselective α-blockers contain haloalkylamine or imidazoline moieties. Phenoxybenzamine, with a haloalkylamine...
Adrenergic Antagonists: Pharmacological Actions of β-Receptor Blockers
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme (ECE). Of...
Adrenergic Antagonists: Pharmacological Actions of ɑ-Receptor Blockers
α1-blockers: These drugs inhibit α1-adrenoceptors on smooth muscle cells, resulting in vasodilation. This vasodilation lowers blood pressure, making α1-blockers valuable in treating hypertension. Additionally, α1-blockers effectively address urinary obstruction...


